NYSE:CAHHealthcare
Does Cardinal Health’s (CAH) Raised 2025 Outlook Recast Its Pharma-Led Strategy as a Durable Edge?
Earlier in fiscal 2025, Cardinal Health reported a strong start to the year, with its Pharma and Specialty Solutions segment driving a 16% segment profit increase and prompting the company to raise its full-year EPS and adjusted free cash flow outlook.
The company’s decision to lift guidance, despite a large customer transition and added health and welfare costs, underscores management’s confidence in Pharma-led growth initiatives and investments such as the pending acquisition of Integrated...